The Czech Mate case provides an opportunity to examine the causes and consequences of expropriation by an important insider in a weak institutional environment. Some of the important points (not an exhaustive list) are:
How insiders can expropriate value from shareholders in emerging markets when property rights are ill-defined?
How institutions and legal rules impact financing patterns and economic outcomes?
Should CME buy Zeleny's shares?
If CME does buy the shares, what should it be worried about? What else can CME do at this point?